GOLDMAN SACHS GROUP INC - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 173 filers reported holding KARUNA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.8%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,963,635
-72.2%
35,269
-64.3%
0.00%
-75.0%
Q2 2023$21,447,332
-28.9%
98,904
-40.5%
0.00%
-33.3%
Q1 2023$30,174,582
-20.3%
166,123
-13.7%
0.01%
-25.0%
Q4 2022$37,837,451
+7.7%
192,557
+23.2%
0.01%0.0%
Q3 2022$35,144,000
+48.7%
156,246
-16.4%
0.01%
+60.0%
Q2 2022$23,642,000
+22.7%
186,877
+23.0%
0.01%
+25.0%
Q1 2022$19,267,000
-18.9%
151,955
-16.2%
0.00%0.0%
Q4 2021$23,745,000
+6.7%
181,263
-0.3%
0.00%0.0%
Q3 2021$22,252,000
+5.6%
181,898
-1.6%
0.00%0.0%
Q2 2021$21,074,000
+9.9%
184,875
+16.0%
0.00%
-20.0%
Q1 2021$19,168,000
+30.6%
159,434
+10.3%
0.01%
+25.0%
Q4 2020$14,682,000
+106.6%
144,516
+57.2%
0.00%
+100.0%
Q3 2020$7,108,000
+83.8%
91,925
+164.9%
0.00%
+100.0%
Q2 2020$3,868,000
+230.6%
34,703
+113.6%
0.00%
Q1 2020$1,170,000
-1.8%
16,244
+2.8%
0.00%
Q4 2019$1,191,000
-22.2%
15,809
-79.3%
0.00%
Q2 2019$1,531,00076,4700.00%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 2,912,872$369,323,00052.78%
Pivotal bioVenture Partners Investment Advisor LLC 852,708$108,115,00051.15%
Sofinnova Investments, Inc. 1,953,077$247,631,00018.79%
Nan Fung Group Holdings Ltd 234,811$29,772,00014.12%
Sands Capital Ventures, LLC 267,895$33,966,0007.10%
Logos Global Management LP 340,000$43,109,0005.59%
DAFNA Capital Management LLC 82,053$10,403,0002.71%
Ghost Tree Capital, LLC 60,000$7,607,0001.65%
CATALYST PRIVATE WEALTH, LLC 24,976$3,167,0001.58%
Eventide Asset Management 748,000$94,839,0001.49%
View complete list of KARUNA THERAPEUTICS INC shareholders